Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

2018315 citationsJournal Articlebronze Open Access

Authors

clinicaltrials.gov Identifier: NCT01627249.

Published in: JAMA Ophthalmology

Volume 136, Issue 3, pp. 257-257

Field-Weighted Citation Impact: 26.45